CIK 0001566044
- Non-accelerated filer
- Smaller reporting company
Yarrow Bioscience, Inc.
Sign in to watch- Ticker
- YARW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 453757789
- Phone
- +1 203-433-7577
- Business address
- 470 JAMES STREET, SUITE 007, NEW HAVEN, CT, 06513
- Former names
- VYNE Therapeutics Inc., Menlo Therapeutics Inc., Menlo Therapeutics, Inc., Tigercat Pharma, Inc.
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 3,420 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF SCIENTIFIC OFFICER gave up 2,453 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF LEGAL OFFICER AND GC gave up 3,581 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT AND CEO gave up 12,676 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 3,420 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF SCIENTIFIC OFFICER gave up 2,453 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF LEGAL OFFICER AND GC gave up 3,581 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT AND CEO gave up 12,676 shares (to pay taxes)
- 4 Grant or award CHIEF LEGAL OFFICER AND GC acquired 1,145 shares (grant or award)
- 4 Grant or award PRESIDENT AND CEO acquired 8,681 shares (grant or award)
- 4 Shares withheld for taxes CHIEF FINANCIAL OFFICER gave up 8,399 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF SCIENTIFIC OFFICER gave up 6,044 shares (to pay taxes)
- 4 Shares withheld for taxes CHIEF LEGAL OFFICER AND GC gave up 8,828 shares (to pay taxes)
- 4 Shares withheld for taxes PRESIDENT AND CEO gave up 30,498 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 15,000 shares at $2.92 ($43,800)
Page 3 of 17 · 330 filings